These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6170430)

  • 21. PCNU: a new nitrosourea in clinical oncology.
    Poster DS; Penta JS; Bruno S
    Am J Clin Oncol; 1982 Feb; 5(1):9-12. PubMed ID: 7081143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I-II diaziquone chemotherapy in brain tumors.
    Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
    Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung.
    Fuks JZ; Aisner J; Van Echo DA; Levitt M; Ihde DC; Carney D; Wiernik PH
    Am J Clin Oncol; 1983 Apr; 6(2):171-3. PubMed ID: 6299094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
    Griffin JP; Newman RA; McCormack JJ; Krakoff IH
    Cancer Treat Rep; 1982 Jun; 66(6):1321-5. PubMed ID: 7083235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography determination of an antineoplastic aziridinylbenzoquinone in human and murine serum.
    Allen BA; Newman RA; Griffin JP; McCormack JJ
    J Chromatogr; 1981 Jan; 222(1):146-51. PubMed ID: 7217323
    [No Abstract]   [Full Text] [Related]  

  • 26. Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
    Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD
    Am J Clin Oncol; 1983 Oct; 6(5):577-8. PubMed ID: 6613923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of aziridinylbenzoquinone (NSC 182986).
    Bedikian AY; Bodey GP; Burgess MA; Freireich EJ
    Cancer Clin Trials; 1981; 4(4):459-63. PubMed ID: 7318128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
    Forastiere AA; Crain SM; Callahan K; Van Echo D; Mattox D; Thant M; Von Hoff DD; Wiernik PH
    Cancer Treat Rep; 1982 Dec; 66(12):2097-8. PubMed ID: 6892491
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase I trial of PCNU administered by 5-day courses.
    Earhart RH; Koeller JM; Davis HL
    Cancer Treat Rep; 1981; 65(9-10):835-40. PubMed ID: 7273016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An experimental model for treatment of mesothelioma.
    Smith WE; Hubert DD; Holiat SM; Sobel HJ; Davis S
    Cancer; 1981 Feb; 47(4):658-63. PubMed ID: 7226014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of aziridinylbenzoquinone and cis-platinum with radiation therapy in the 9L rat brain tumor model.
    Kimler BF; Liu C; Evans RG; Morantz RA
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):445-50. PubMed ID: 8514542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).
    Carey RW; Comis RL; Anbar D; Kennedy BJ; Capizzi RL; Shulman P; Booth BW; Green M; Raich PC
    Cancer Treat Rep; 1983 Jan; 67(1):95-6. PubMed ID: 6616498
    [No Abstract]   [Full Text] [Related]  

  • 34. Aziridinylbenzoquinone (AZQ) treatment of central nervous system leukemia.
    Kamen BA; Holcenberg JS; Siegel SE
    Cancer Treat Rep; 1982 Dec; 66(12):2105-6. PubMed ID: 6958367
    [No Abstract]   [Full Text] [Related]  

  • 35. Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
    Samuels BL; Herndon JE; Harmon DC; Carey R; Aisner J; Corson JM; Suzuki Y; Green MR; Vogelzang NJ
    Cancer; 1998 Apr; 82(8):1578-84. PubMed ID: 9554537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
    Schold SC; Friedman HS; Bjornsson TD; Bigner DD
    Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat.
    Moore DJ; Powis G; Richardson RL; Pittelkow MR
    Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
    McLaughlin P; Cabanillas F; Bedikian AY; Bodey GP
    Cancer Treat Rep; 1983 May; 67(5):507-8. PubMed ID: 6850666
    [No Abstract]   [Full Text] [Related]  

  • 39. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.
    Jänne PA; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Taylor L; Ashland J; Ye Z; Monberg MJ; Obasaju CK
    Clin Lung Cancer; 2005 Jul; 7(1):40-6. PubMed ID: 16098243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of Bacillus megaterium H. in studying the antitumor properties of new ethyleneimine derivatives of N-dichlorophosphonyliminotri-chloroacetic acid trichlorophosphopolyalkane halides and chloroanhydridies].
    Kutovoĭ AI; Siadro TA; Petrenko VS; Solodushchenko GF; Teliuk VG
    Mikrobiol Zh; 1978; 40(5):633-6. PubMed ID: 723679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.